Yan Leyfman: Episode 3 of The Translational Edge on Cancer Anticoagulation Is Now Live on Shuf
Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, Medical Correspondent at OncLive, shared Jeremy Bellaiche‘s post on LinkedIn, adding:
“Episode 3 of The Translational Edge is now live on Shuf.
As oncology care becomes more personalized, one critical question remains:
Are we dosing based on evidence—or outdated assumptions?
This episode explores the evolving science of anticoagulation in cancer patients with obesity—and how aligning practice with data can directly impact outcomes.
Translating breakthroughs into impact.
Jeremy Bellaiche, Founder of Shuf, shared a post on LinkedIn:
“Excited to share the episode 3 of The Translational Edge season 2 with Yan Leyfman exclusively on Shuf !
Treating Blood Clots in Cancer Patients with Obesity: Why Dosing Finally Caught Up with Reality.”
Stay updated with Hemostasis Today.
-
Mar 26, 2026, 16:39Faizan Khan: Cold Agglutinins and Their Effects on CBC Results
-
Mar 26, 2026, 16:38Strengthening Research and Partnerships at THSNA 2026 – NBDF
-
Mar 26, 2026, 16:38Gareth Owens: Advancing Patient Engagement in Cardiothoracic Surgery
-
Mar 26, 2026, 15:50Vicky Kumar: How Best to Manage Patients with Patent Foramen Ovale After a Cryptogenic Stroke
-
Mar 26, 2026, 15:47Edward Lee Carter: Are All DOACs Truly Interchangeable in Real-World Practice?
-
Mar 26, 2026, 15:46Faizan Khan: Key Findings on Long Term Stroke Risk After TIA and Minor Stroke
-
Mar 26, 2026, 15:441 in 4 Will Have a Stroke, It is More Common than People Think and It Does Not Discriminate – European Stroke Organisation
-
Mar 26, 2026, 15:39Fabrice Cognasse: Platelets May Play a Much Broader Role in Regulating Inflammation
-
Mar 26, 2026, 15:27Maxime Dely: Anticoagulant Is an Invisible Yet Essential Ally of Therapeutic Apheresis